Where can I buy CoDIAK Biosciences (cdak) stock?
Shares of CDAK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Codiak BioSciences' stock price today?
Where can I buy shares of cdak?
Shares of CDAK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
When is CoDIAK Biosciences'next quarterly earnings announcement?
Codiak BioSciences is scheduled to release its next quarterly earnings announcement on Wednesday, March 16th 2022. View our earnings forecast for Codiak BioSciences. How were Codiak BioSciences' earnings last quarter? Codiak BioSciences, Inc. (NASDAQ:CDAK) released its quarterly earnings results on Thursday, November, 4th.
See more
Should I buy or sell Codiak BioSciences stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Codiak BioSciences in the last twelve months. There are currently...
What is Codiak BioSciences' stock price forecast for 2022?
2 Wall Street analysts have issued 1-year price targets for Codiak BioSciences' stock. Their forecasts range from $8.00 to $24.00. On average, they...
How has Codiak BioSciences' stock performed in 2022?
Codiak BioSciences' stock was trading at $11.14 at the start of the year. Since then, CDAK stock has decreased by 74.1% and is now trading at $2.89...
When is Codiak BioSciences' next earnings date?
Codiak BioSciences is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for C...
How were Codiak BioSciences' earnings last quarter?
Codiak BioSciences, Inc. (NASDAQ:CDAK) released its earnings results on Thursday, May, 5th. The company reported ($0.36) earnings per share (EPS) f...
Who are Codiak BioSciences' key executives?
Codiak BioSciences' management team includes the following people: Dr. Douglas Edward Williams Ph.D. , Pres, CEO & Director (Age 64, Pay $970.77...
Who are some of Codiak BioSciences' key competitors?
Some companies that are related to Codiak BioSciences include Adaptimmune Therapeutics (ADAP) , Social Capital Suvretta Holdings Corp. III (DNAC)...
When did Codiak BioSciences IPO?
(CDAK) raised $82 million in an initial public offering on Wednesday, October 14th 2020. The company issued 5,500,000 shares at $14.00-$16.00 per s...
What is Codiak BioSciences' stock symbol?
Codiak BioSciences trades on the NASDAQ under the ticker symbol "CDAK."
About Codiak BioSciences
Headlines
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases.
Codiak BioSciences (NASDAQ:CDAK) Frequently Asked Questions
What Type Of Shareholders Make Up Codiak BioSciences, Inc.'s (NASDAQ:CDAK) Share Registry?
How much is Codiak Biosciences stock worth in 2021?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Codiak BioSciences in the last twelve months. There are currently 3 buy ratings for the stock.
What does $17.97 mean?
The Codiak Biosciences Inc. stock price gained 1.12% on the last trading day (Friday, 9th Jul 2021), rising from $17.86 to $18.06. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 3.51% from a day low at $17.51 to a day high of $18.12. The price has fallen in 7 of the last 10 days and is down by -11.69% for this period. Volume fell on the last day by -50 thousand shares and in total, 50 thousand shares were bought and sold for approximately $896.05 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
News & Analysis: Codiak BioSciences, Inc
If the lower trend floor at $17.97 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.
Environmental, Social, and Governance Rating
There is no available coverage of Codiak BioSciences, Inc. at this time.
